HIV Abdominal Obesity & Insulin Resistance: Treatment with IGF-1/IGFBP-3

HIV Abdominal Obesity & Insulin Resistance: Treatment with IGF-1/IGFBP-3

Effects of treatment with IGF-1/IGFBP-3 on glucose metabolism and fat distribution in HIV-infected patients with abdominal obesity and insulin resistance as and option to Human Growth Hormone with it's undesired side effects. Maury Schambelan, University of California San Francisco, interviewed by Jeff Taylor at the Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, London, November 2008

Discover the facts about obesity , including its most common causes, the effects on health and steps you can take to lose weight.  Your Online Source for Credible Health Information.

---

Orignal From: HIV Abdominal Obesity & Insulin Resistance: Treatment with IGF-1/IGFBP-3